Postoperative Pain for Patients After TA-BSM
Launched by WENLONG YAO (101480) · May 25, 2024
Trial Information
Current as of March 14, 2025
Completed
Keywords
ClinConnect Summary
Since conventional septal myectomy can be only assessed when the heart resumes beating, and the complications induced by cardiopulmonary bypass are inevitable, a novel transapical beating-heart septal myectomy (TA-BSM) has been invented, which provides real-time evaluation to guide resection while reducing surgical trauma. Postoperative pain after TA-BSM is unknown. Whether paravertebral nerve block can improve postoperative pain caused by TA-BSM is the objective of our study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18\~75 years
- • American society of anesthesiologists classification II-III
- • Elective TA-BSM was performed
- Exclusion Criteria:
- • Underwent multiple surgical procedures or required cardiopulmonary bypass assistance
- • Combined other function decompensation disease
- • Patients with incomplete medical records
Trial Officials
Wenlong Yao
Principal Investigator
Tongji Hospital
About Wenlong Yao (101480)
Wenlong Yao (101480) is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic interventions, the organization aims to enhance patient care and treatment outcomes through rigorous clinical studies. Wenlong Yao adheres to the highest ethical standards and regulatory compliance, fostering collaboration with healthcare professionals and research institutions. Their mission is to contribute to the scientific community by facilitating groundbreaking research that addresses unmet medical needs and improves public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
